- Home
- QDEL vs GAM Comparison
QDEL vs GAM Comparison
Compare QDEL & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QDEL | GAM |
|---|---|---|
| Founded | 1979 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | QDEL | GAM |
|---|---|---|
| Price | $29.38 | $58.82 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 857.8K | 20.1K |
| Earning Date | 02-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 11.67 |
| Revenue | ★ $2,714,400,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.42 | N/A |
| P/E Ratio | ★ N/A | $3.95 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.50 | $37.32 |
| 52 Week High | $49.45 | $46.48 |
Technical Indicators
Market Signals| Indicator | QDEL | GAM |
|---|---|---|
| Relative Strength Index (RSI) | 58.54 | 47.82 |
| Support Level | $28.39 | $58.19 |
| Resistance Level | $29.62 | $59.99 |
| Average True Range (ATR) | 1.16 | 0.76 |
| MACD | -0.03 | 0.17 |
| Stochastic Oscillator | 67.00 | 47.36 |
Price Performance
Historical ComparisonAbout QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.